Linked Life Data

11985053

Source:http://linkedlifedata.com/resource/pubmed/id/11985053

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-5-2
pubmed:abstractText
The Japanese Government has developed health-care payment policies designed to balance the growth of health-care expenditure against other national priorities. Often these policies tend to limit the various services. The Japan Atherosclerosis Society published management guidelines for hyperlipidemia in 1997. There is increasing concern about the cost of laboratory studies as well as the cost of the management of hyperlipidemia. The Japanese Society of Laboratory Medicine has also developed standards to choose effective laboratory tests for general practitioners. Health professionals must have a clear knowledge of not only the clinical significance of the laboratory tests but also of the reimbursement system in order to understand the economic factors that control the services available to their patients. Both knowledge can make the physicians proper medical services for the patients.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0047-1860
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
262-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Choosing effective laboratory tests for hyperlipidemia, and the reimbursement system].
pubmed:affiliation
Department of Clinical Pathology, Showa University School of Medicine, Shinagawa-ku, Tokyo 142-8666.
pubmed:publicationType
Journal Article, English Abstract